about
Drug treatment for spinal muscular atrophy type IRasch analysis of clinical outcome measures in spinal muscular atrophy.The Genetics of Spinal Muscular Atrophy: Progress and Challenges.The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability.Therapy development for spinal muscular atrophy in SMN independent targets.
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Drug treatment for spinal muscular atrophy type I
@ast
Drug treatment for spinal muscular atrophy type I
@en
Drug treatment for spinal muscular atrophy type I
@en-gb
Drug treatment for spinal muscular atrophy type I
@nl
type
label
Drug treatment for spinal muscular atrophy type I
@ast
Drug treatment for spinal muscular atrophy type I
@en
Drug treatment for spinal muscular atrophy type I
@en-gb
Drug treatment for spinal muscular atrophy type I
@nl
prefLabel
Drug treatment for spinal muscular atrophy type I
@ast
Drug treatment for spinal muscular atrophy type I
@en
Drug treatment for spinal muscular atrophy type I
@en-gb
Drug treatment for spinal muscular atrophy type I
@nl
P2093
P2860
P1476
Drug treatment for spinal muscular atrophy type I
@en
P2093
Alexander FJE Vrancken
John HJ Wokke
Susan T Iannaccone
Wendy MJ Bosboom
P2860
P356
10.1002/14651858.CD006281.PUB2
P577
2009-01-21T00:00:00Z